Related Experiment Video
Updated: Jan 25, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Published on: September 16, 2020
[Advances in Retinopathy of Prematurity]
Xiao Xuan Xu1, Ya Jun Wu1, Hong Yun Wu2
1Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China.
Insights
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Recent advances include anti-VEGF therapy, surgical treatments, and new drugs targeting growth factors and receptors.
Area of Science:
- Ophthalmology
- Pediatrics
- Neonatology
Background:
- Retinopathy of prematurity (ROP) is a serious condition causing abnormal blood vessel growth in premature infants' eyes.
- It is a primary cause of preventable childhood blindness globally.
- Understanding ROP's pathogenesis has driven significant research.
Purpose of the Study:
- To review recent advancements in the treatment and management of Retinopathy of Prematurity.
- To highlight key therapeutic strategies and drug developments for ROP.
Main Methods:
- Review of current literature on Retinopathy of Prematurity.
- Analysis of established and emerging treatment modalities.
- Summary of pharmacological interventions.
Main Results:
- Anti-vascular endothelial growth factor (anti-VEGF) therapy and surgical interventions are established ROP treatments.
- Development of various therapeutic agents, including insulin-like growth factor-1, transforming growth factor-β, polyunsaturated fatty acids, and β-adrenergic receptor blockers.
- Ongoing research continues to refine ROP management.
Conclusions:
- Significant progress has been made in understanding and treating ROP.
- A combination of therapies offers improved outcomes for premature infants.
- Continued research is vital for further reducing ROP-related vision impairment.
Abstract:
Retinopathy of prematurity(ROP)is a pathological neovascularization with fibrotic changes in the fundus of premature infants.It is a major cause of preventable blindness in children in both developing and developed countries.Treatment of ROP has long been a hot research topic in ophthalmology and pediatrics.With a clearer knowledge of the pathogenesis of ROP,more basic and clinical studies have been carried out.The anti-vascular endothelial growth factor therapy and surgical treatment have become mature strategies,and a variety of therapeutic drugs including insulin-like growth factor-1,transforming growth factor-β,polyunsaturated fatty acids,and β-adrenergic receptor blockers have been developed.This article reviews the recent advances in ROP.
Related Concept Videos
Extraction: Advanced Methods
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Mutations
Improving Translational Accuracy

